Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

Denning, D.W., Cadranel, J., Beigelman-Aubry, C., et al.

Source: Guideline 2016

Number: 2016

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Denning, D.W., Cadranel, J., Beigelman-Aubry, C., et al.. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Guideline 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Suzanne Ringrow - 29.08.2017 16:15
Test was good but software poor, wouldn't allow easy progression through the questions once they were answered

You must Login to comment this presentation.

Related content which might interest you:

Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines Source: Eur Respir Rev 2014; 23:193-214 Year: 2014
Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009
Impact of guidelines for the management of pulmonary embolism in clinical practice Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines Year: 2019
Pulmonary aspergillosis: a clinical review Source: Eur Respir Rev 2011; 20: 156-174 Year: 2011
Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011 Source: Eur Respir J 2011; 37: 743-746 Year: 2011
Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 243-244 Year: 2002
Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Clinical features of COPD in patients with chronic pulmonary aspergillosis Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
Guidelines for the diagnosis and treatment of pulmonary hypertension Source: Eur Respir J 2009; 34: 1219-1263 Year: 2009
Guidelines for the diagnosis and treatment of pulmonary hypertension Source: Guideline 2009 Year: 2009
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension Source: Eur Respir Rev, 31 (163) 210165; 10.1183/16000617.0165-2021 Year: 2022
Clinical characteristics and prognosis of chronic pulmonary aspergillosis Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019
Chronic obstructive pulmonary disease (COPD) assessment service: guidelines for referral and accuracy of clinical assessment Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005
Pulmonary hypertension: new guidelines for therapy Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment Year: 2007
Pulmonary aspergillosis – diagnostic and therapeutic challenges Source: Eur Respir J 2005; 26: Suppl. 49, 170s Year: 2005
Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice Source: Eur Respir J 2013; 41: 1252-1256 Year: 2013
Pulmonary aspergilloma: clinical findings and surgical treatment Source: Eur Respir J 2006; 28: Suppl. 50, 274s Year: 2006
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020 Year: 2020